Report overview
Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Others possible symptoms include nausea and vomiting, bloating, loss of appetite and heartburn. Complications may include bleeding, stomach ulcers, and stomach tumors.
This report contains market size and forecasts of Gastritis Treatment Drugs in global, including the following market information:
Global Gastritis Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastritis Treatment Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Gastritis Treatment Drugs companies in 2021 (%)
The global Gastritis Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acid-Blocking Medicines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastritis Treatment Drugs include Pfizer, AstraZeneca, Novartis, Cipla, Abbott Laboratories, Microbiotix, Reddy's Laboratories, Lupin Ltd and Perrigo Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastritis Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastritis Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Gastritis Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Acid-Blocking Medicines
Antibiotics
Antacids
Histamine Blockers
Others
Global Gastritis Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Gastritis Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Gastritis Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Gastritis Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastritis Treatment Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastritis Treatment Drugs revenues share in global market, 2021 (%)
Key companies Gastritis Treatment Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Gastritis Treatment Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Novartis
Cipla
Abbott Laboratories
Microbiotix
Reddy's Laboratories
Lupin Ltd
Perrigo Pharmaceutical
Sun Pharmaceutical Industries
